We ran a very successful Social Media workshop on 12th November, with thanks to Celgene for their support. It was attended by 10 members...

Our thanks to Stopgap who have donated £400 to Cancer52. Stopgap is a small (50 people) owner managed business which finds marketing...

We are pleased to share the presentations delivered at the quarterly All Stakeholders Briefing on 21st October 2015 at the Royal College...

Chair Jonathan Pearce is interviewed on BBC Radio 4's Inside Health Programme on the Cancer Drug Fund and the extra challenges faced by...

Jonathan Pearce, Chair of Cancer52, said: "Cancer52 calls on NHS England to learn from The National Audit Office’s report[1] and ensure...

Cancer52 comment on Cancer Drug Fund announcement of 4 September 2015.

The Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020 was published in July 2015. Cancer52, a coalition of more...

We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is...

On 15th June 2015, Cancer52 responded to the proposed changes to the Standard Operating Procedures: Cancer Drugs Fund 2015-16. In...

We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is...